Annexin A1 (ANXA1) Peptid
ANXA1
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle Annexin a1 (ANXA1) Produkte
- Annexin a1 (ANXA1) (Annexin A1 (ANXA1))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- TFNPSSDVAA LHKAIMVKGV DEATIIDILT KRNNAQRQQI KAAYLQETGK
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ANXA1 antibody,
Alternative Names: ANXA1 control peptide, ANXA1 antibody Blocking Peptide, Anti-ANXA1 Blocking Peptide, annexin A1 Blocking Peptide, ANX1 Blocking Peptide, LPC1 Blocking Peptide, ANXA1, ANXA-1, ANXA 1, ANXA-1 Blocking Peptide, ANXA 1 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- Annexin a1 (ANXA1) (Annexin A1 (ANXA1))
- Hintergrund
- Annexin I belongs to a family of Ca(2+)-dependent phospholipid binding proteins which have a molecular weight of approximately 35,000 to 40,000 and are preferentially located on the cytosolic face of the plasma membrane. Annexin I protein has an apparent relative molecular mass of 40 kDa, with phospholipase A2 inhibitory activity. Since phospholipase A2 is required for the biosynthesis of the potent mediators of inflammation, prostaglandins and leukotrienes, annexin I may have potential anti-inflammatory activity.
- Molekulargewicht
- 39 kDa
-
Sie sind hier:
